NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia
Cited by 5
Related Papers
Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway
|Molecular Cancer|2015|103
Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
|Oncology Reports|2016|51
Verdinexor, a Selective Inhibitor of Nuclear Exportin 1, Inhibits the Proliferation and Migration of Esophageal Cancer via XPO1/c-Myc/FOSL1 Axis
|International Journal of Biological Sciences|2021|17
Anticancer roles of let‑7f‑1‑3p in non‑small cell lung cancer via direct targeting of integrin β1
|Experimental and Therapeutic Medicine|2021|7
Epigenome Editing Durability Varies Widely Across Cardiovascular Disease Target Genes
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2